Evidence map›Paper›PMID 11371630›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

BRCA1 at a branch point.

J D Parvin

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. BRCA1 and BRCA2 in breast cancer predisposition and recombination control.Journal of mammary gland biology and neoplasia · 2004
    Article
  7. Article
  8. Article
  9. Review
  10. Emerging roles of BRCA1 alternative splicing.Molecular pathology : MP · 2003
    Review
  11. Article
  12. Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

J D ParvinDepartment of Pathology, Harvard Medical School, and Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. jparvin@rics.bwh.harvard.edu

Funding

TFIIH HELICASES AND RNA POLYMERASE II HOLOENZYMER01GM053504 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI PARVIN, JEFFREY D · 1996 to 2005
$1.6M
NIGMS NIH HHS NIGMS 53504
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA DamageDNA RepairNuclear ProteinsTumor Suppressor ProteinsUbiquitin-Protein LigasesAnimalsBRCA1 ProteinCarrier ProteinsCell Cycle ProteinsDNADNA-Binding ProteinsDNA Polymerase IIExodeoxyribonucleasesHoloenzymesHumansMRE11 Homologue ProteinBARD1 protein, humanBRCA1 ProteinCarrier ProteinsCell Cycle ProteinsDNADNA-Binding ProteinsDNA Polymerase IIExodeoxyribonucleasesHoloenzymesMRE11 Homologue ProteinMRE11 protein, humanNBN protein, humanNuclear ProteinsRAD51 protein, humanRad51 RecombinaseTumor Suppressor ProteinsUbiquitin-Protein LigasesUbiquitins

Identifiers

PMID11371630
PMCPMC33402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.